Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis

Br J Haematol. 2018 Jul;182(1):145-148. doi: 10.1111/bjh.14747. Epub 2017 May 9.

Affiliations

¹ National Amyloidosis Centre, University College London, London, U.K.
² Division of Medicine, UCL Centre for Nephrology, University College London, London, U.K.
³ Cardiology Department, Royal Free Hospital, London, U.K.

PMID: 28485005
DOI: 10.1111/bjh.14747

No abstract available

Keywords: Cardiac AL amyloidosis; amyloidosis; arrhythmias; implantable cardioverter-defibrillator (ICD); infiltrative cardiomyopathies.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Cardiomyopathies / complications
Cardiomyopathies / therapy*
Death, Sudden, Cardiac / etiology
Death, Sudden, Cardiac / prevention & control
Defibrillators, Implantable*
Humans
Immunoglobulin Light-chain Amyloidosis / complications
Immunoglobulin Light-chain Amyloidosis / therapy*
Middle Aged